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Cartilage–hair hypoplasia (CHH) is caused by mutations in the gene encoding the RNA component of RNase MRP. Currently it is unknown
how these mutations affect the function of this endoribonuclease. In this study we investigated the effect of mutations in the P3 domain on protein
binding and RNA folding. Our data demonstrate that a number of P3 nucleotide substitutions reduced the efficiency of its interaction with Rpp25
and Rpp20, two protein subunits binding as a heterodimer to this domain. The CHH-associated 40GNA substitution, as well as the replacement of
residue 47, almost completely abrogated Rpp25 and Rpp20 binding in different assays. Also other CHH-associated P3 mutations reduced the
efficiency by which the RNase MRP RNA is bound by Rpp25–Rpp20. These data demonstrate that the most important residues for binding of the
Rpp25–Rpp20 dimer reside in the apical stem-loop of the P3 domain. Structural analyses by NMR not only showed that this loop may adopt a
pseudo-triloop structure, but also demonstrated that the 40GNA substitution alters the folding of this part of the P3 domain. Our data are the first to
provide insight into the molecular mechanism by which CHH-associated mutations affect the function of RNase MRP.
© 2007 Elsevier B.V. All rights reserved.Keywords: Cartilage–hair hypoplasia; Endoribonuclease; RNA processing; RNase MRP; RNA-protein interaction1. Introduction
Cartilage–hair hypoplasia (CHH: OMIM #250250) [1] was
the first recessively inheritable human autosomal developmental
disorder described to be caused by mutations in a non-coding
structural RNA. The affected gene, first identified by Ridanpää
et al. [2], codes for the 267 nucleotides long RNA component of
the RNase MRP small nucleolar ribonucleoprotein complex
(snoRNP) [3]. The major CHH-pathogenic mutation in the RNA
component of the RNase MRP complex is the single nucleotide
substitution 70ANG [2]. This mutation can be detected in more
than 90% of all reported CHH-cases [4] and was calculated to
originate from a single mutation event, which took place 3900–
4800 years ago [5,6]. In contrast to most known snoRNPs, the⁎ Corresponding author. Tel.: +31 24 361 6847; fax: +31 24 354 0525.
E-mail address: G.Pruijn@NCMLS.RU.NL (G.J.M. Pruijn).
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2007.11.016RNase MRP complex is not involved in posttranscriptional
nucleotide modification of ribosomal RNA (rRNA), but in the
endonucleolytic cleavage of precursor 5.8S rRNA [7] and other
ribonucleolytic cleavage events [8,9]. RNase MRP is highly
related to the pre-tRNA processing factor RNase P [10], from
which the RNA subunit was the first RNA for which ribozyme
activity was described [11].
To understand the molecular mechanism behind CHH it is
important to know that the major RNase MRP RNA mutation
that is associated with CHH is situated close to the crucial P4
long-range interaction of RNase MRP RNA and is part of a
short single stranded nucleotide stretch referred to as the J3/4
domain [12]. The J3/4 domain is highly conserved among all
known RNase MRP and RNase P RNA species and previous
studies on the J3/4 domain in the Escherichia coli RNase P
RNA provided evidence for divalent metal ion binding sites in
this domain that are crucial for the enzymatic activity of the
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related mutation 70ANG directly affects the catalytic activity
of RNase MRP. Recently, it was shown that overexpression
of the RNase MRP RNA 70ANG mutant in human fibroblasts
indeed reduced the expression level of 5.8S rRNA [14].
In addition to the 70ANG mutation, a high number of other
mutations in the RNase MRP RNA gene have been described,
which are located either in the promoter or in the transcribed
region of the gene. In the transcribed part 57 different CHH-
associated insertions and substitutions have been found to date
[14] (reviewed by Bonafé et al. [4]; unpublished data), which
means that almost 20% of the nucleotides may be implicated in
CHH. Most of these alleles, like 70ANG, are expected to di-
minish the catalytic activity of RNase MRP. Insight into the
secondary and tertiary structures of RNase MRP RNA has been
obtained by chemical/enzymatic structure probing and phylo-
genetic comparison [15,16,17] as well as from extrapolation ofTable 1
Oligonucleotides used for NMR and mutational analysis of the P3 domain
RNA oligonucleotides (NMR) Sequence (5′–3′)
P3bwt GGAGGACUCUGUUCCUCC
P3b40GNA GGAGAACUCUGUUCCUCC
DNA oligonucleotides (mutagenesis) Sequence (5′–3′)
TH-8 GCGAATTCTAATACGACTCACTAT
P3f5 TAATACGACTCACTATACCTAGGC
P3f6 GCGAATTCTAATACGACTCACTAT
P3f7 GCGAATTCTAATACGACTCACTAT
P3f8 GCGAATTCTAATACGACTCACTAT
P3f9 GCGAATTCTAATACGACTCACTAT
P3f10 GCGAATTCTAATACGACTCACTAT
P3f11 GCGAATTCTAATACGACTCACTAT
P3f12 GCGAATTCTAATACGACTCACTAT
P3f13 GCGAATTCTAATACGACTCACTAT
P3r2 CCTAGGCGGAAAGGGGAGGAAC
P3r7 TTTCCCCTAGGCGGAAAGGGGAG
P3r8 TTTCCCCTTCCCGGAAAGGGGAG
P3r9 TTTCCCCTAGGCGGAAAGGGGAG
P3r10 TTTCCCCTAGGCGGAAAGGGGTC
P3r11 TTTCCCCTAGGCGGAAAGGGGAG
P3r12 TTTCCCCTAGGCGGAAAGGGGAG
P3r13 TTTCCCCTAGGCGGTTTGGGGAG
P3r14 GGCCTAGGCGGAAAGGGGAGGA
P3r15 TTTCCCCTAGGCGGAAAGGGGAG
P3r16 TTTCCCCTAGGCGGAAAGGGGAG
P3r17 TTTCCCCTAGGCGGAAAGGGGAG
P3r18 TTTCCCCTAAGCGGAAAGGGGAG
P3r19 TTTCCCCTGGGCGGAAAGGGGAG
P3r20 TTTCCCCTAGGCGGAAAGGGGAG
MRP-S1-158 CCGCCAAGAAGCGTAATCGATAA
GGGCCGGGGGCGTATTATGTGCG
MRPgenfwd GCTATTCTGCTAGCCACAATGCC
MRPgenrev CGTATGCACGTGGCACTCTCTGC
fwdCHH35CNT CCTAGGCTACACATTGAGGACTC
fwdCHH40GNA GGCTACACACTGAGAACTCTGTT
fwd47TNC CTGAGGACTCTGCTCCTCCCCTT
fwdCHH63CNT CCCCTTTCCGCTTAGGGGAAAGT
fwdCHH64TNC CCCCTTTCCGCCCAGGGGAAAGT
fwdCHHdup CACTGAGGACTCTGTTCCTCCTG
MRPfwd GCGAATTCTAATACGACTCACTAT
MRPrev GCGAAGCTTGTACAGCCGCGCTGX-ray crystallography data for RNase P [45]. Interestingly, the
vast majority of the CHH mutations are located in evolutionarily
highly conserved regions, many of which are involved in in-
tramolecular base pairing [4]. Similarly, mutations in the RNA
component of human telomerase RNA (hTR), which are asso-
ciatedwith the genetic disorder dyskeratosis congenita (DKC), are
located in highly conserved domains of hTR. Subtle alternative
hTR structures, caused byDKC-associatedmutations, are thought
to explain DKC at least in a number of cases [18].
One of the RNase MRP RNA domains, which has been re-
ported to be involved in the interactionwith protein subunits, is the
P3 domain. A phylogenetic comparison showed that there is a
high degree of sequence similarity among the RNase MRP P3
domains of several vertebrate species [4,44]. The hPop1, Rpp20
and Rpp25 proteins bind to this domain [19–21], which is es-
sential for the nucleolar localization of the RNaseMRP RNA [22]
and is important for ribonucleoprotein particle assembly [23]. InAGGCCTAGGCTACACACTGAGG
TACACACTGAGG
AGGCCTTCCCTACACACTGAGGACTCTGTTCC
AGGCCTAGGCCGTACACTGAGGACTCTGTTCC
AGGCCTAGGCTACACGTTGAGGACTCTGTTCC
AGGCCTAGGCTACACACTGTCCACTCTGTTGG
AGGCCTAGGCTACACATTGAGGACTCTGTTCC
AGGCCTAGGCTACACACTGAGAACTCTGTTCCTCCC
AGGCCTAGGCTACACACTGAGGTCTCTGTACC
AGGCCTAGGCTACACACTGAGGATTCTGTTCCTCCC
AGAGTCCTC
GAACAGAGTCCTCAGTGTGTAGCC
GAACAGAGTCC
GAACAGAGTCC
CAACAGAGTGG
GATCAGACTCCTCAGTGTGTA
GAGCAGAGTCCTCAGTGTGTA
GAACAGAGTCCTCAGTGTGTA
ACAGAGTCC
GAACAGA
GTACAGAGACC
GAATAGAGTCCTCAGTGTGTA
GAACAGAGTCCTCAGTGTGTA
GAACAGAGTCCTCAGTGTGTA
GAACAGGAGGAACAGAGTCCTCAGTGTGTA
AAGGGAGTCGACCGACCAGAATCATGCAAGTGCGTAAGATAGTCGC-
TCTACATCTAGACTCATAAAAATCGATTCCCGCTGAGCGGCG
TGTTCC
CCTCC
TCC
CC
CC
TTCCTCCCCTTTCCGCCTAGGGG
AGTTCGTGCTGAAGGCCTGTATCC
AGAATGAGCC
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tations were originally not found in the P3 domain [6]. However,
recently Bonafé and collaborators showed the occurrence of se-
veral different P3 mutations in CHH patients [4]. One of the P3
domain-binding proteins, Rpp25, associateswith the P3 domain in
a manner that is dependent on the proper folding of this domain
[24].
To provide more insight into the molecular mechanism by
which (CHH-associated) mutations in the P3 domain affect
RNase MRP function, we investigated the effect of these muta-
tions on its recognition by the protein subunits and on its structure.
Our results show that a number of P3 domain mutations dras-
tically affect the binding of Rpp20 and Rpp25, two protein sub-
units which are likely to play a crucial role in the biological
function of RNase MRP [25,21]. At least for some of the muta-
tions the interferencewithRpp25-binding appears to be caused by
structural alterations in the P3 domain.
2. Materials and methods
2.1. In vitro transcription of P3 RNAs
The RNase MRP RNA constructs MRP1-82 and MRP22-67 have been des-
cribed previously and were linearized as described before [19]. For in vitro trans-
cription, 1μg templateDNAwas incubated for 1 h at 37 °C in 20μl buffer containing
40 mM Tris–HCl, pH 7.9; 6 mMMgCl2; 2 mM spermidine; 10 mMNaCl; 10 mM
dithiotreitol; 1 mMATP; 1 mMCTP; 1 mMGTP; 0.1 mMUTP; 6.6 fmol (20 μCi)
[α-32P]UTP and 15 U T7 RNA polymerase. After transcription, the RNA was
purified by phenol/chloroform/isoamylalcohol (25:24:1) extraction and unincorpo-
rated nucleotides were removed using a Sephadex G50 spin column. Templates for
mutant P3 RNAs were generated by PCR using overlapping oligonucleotides
containing the T7 RNA polymerase promoter sequence in the ‘forward’ oli-
gonucleotide. Combinations of the oligonucleotides used (see Table 1) are as
follows: P3: P3f5×P3r2; P3GGAA: P3f5×P3r7; GGP3: TH-8×P3r2; GGP3GGAA/wt:
TH-8×P3r7; 1: P3f6×P3r8; 2: P3f7×P3r9; 3: P3f8×P3r9; 4: P3f9×P3r10; 5:
TH-8×P3r11; 6: TH-8×P3r12; 7: TH-8×P3r13; 8: P3f10×P3r9; 9: P3f11×P3r15;
10: P3f12×P3r16; 11: P3f13×P3r15; 12: TH-8×P3r17; 13: TH-8×P3r18; 14:
TH-8×P3r19; 15: TH-8×P3r20. The oligonucleotides (50 pmol each) were an-
nealed and elongated using TaqDNA polymerase and 0.5 mM dNTPs in a standard
PCR-buffer. For in vitro transcription and radiolabeling, one μg of purified PCR
template was transcribed for 1 h in transcription buffer supplemented with [α-32P]
UTP and the products were purified as described above.
2.2. GST pull-down assay
GST and GST-Rpp25 were bacterially expressed and purified as described
before [26]. Protein-RNA interaction analysis was performed by coupling 0.5 pmol
GSTorGST-Rpp25 to 10μl glutathione-Sepharose beads (GEHealthcare) in 500μl
PB-200 (20 mM HEPES/KOH, pH 7.6; 200 mM KCl; 0.5 mM EDTA; 0.05%
Nonidet P-40; 1mMdithioerytritol (DTE); 5mMMgCl2). After coupling, the beads
were resuspended in 100 μl PB-200 and 10 μl RNA mixture (composition: 50 ng
radiolabeled (mutant) P3 RNA and/or 50 ng radiolabeled MRP1-82 RNA; 40 U
RNasin; 5 μg E. coli tRNA) was added. After incubation for 1 h under continuous
agitation at 4 °C, the beads were washed 3 times with 500 μl PB-200 and resus-
pended in 15 μl urea-dye/phenol (7 M urea; 1× TBE; 0.083% xylene cyanol FF;
0.083% bromophenol blue; 20% (v/v) phenol). The samples were heated for 5 min
at 100 °C and the co-precipitating RNAswere separated by denaturing PAGE (15%
polyacrylamide gels). RNAs were visualized by autoradiography and quantified by
phosphorimaging. The MRP1-82 RNAwas used as an internal positive control for
precipitation by GST-Rpp25. To determine the precipitation efficiency of the
(mutant) P3 RNA, the phosphorimaging signals of the precipitated MRP1-82 and
(mutant) P3 RNA were corrected for the GST background and the ratio of the
precipitated RNAs was compared to the ratio of the input RNAs to calculate the
relative pull-down efficiency (RPE).2.3. Generation of S1-aptamer tagged RNase MRP RNA
A pcDNA3 (Invitrogen) -based construct encoding an S1 streptavidin-aptamer
tagged [27] human RNase MRP RNA under transcriptional control of the original
promoter of the human gene for RNaseMRPRNAwas generated. The aptamer tag
(104 nucleotides, including flanking residues) was inserted between nucleotides
158 and 159 of RNase MRP RNA by PCR-directed mutagenesis using oli-
gonucleotide MRP-S1-158 (see Table 1). A spacer element between the RNase
MRP RNA and the tag was included, as described for a similar tagged human
RNase P RNA construct [23]. Similar constructs containing mutations in the P3
domain were obtained from the tagged wild type RNase MRP RNA construct by
PCR-based mutagenesis using the following oligonucleotides: fwdCHH35CNT,
fwdCHH40GNA, fwd47TNC, fwdCHH63CNT, fwdCHH64TNC, and fwdCHHdup
(see Table 1). The products of PCR reactions with these oligonucleotides in
combination with a general reverse oligonucleotide (MRPgenrev) were used to
substitute the corresponding fragment of the wild type construct. Sequence analysis
confirmed the sequence of the constructs described above. Templates for in vitro
transcription were generated from these constructs by PCR using a forward oli-
gonucleotide (MRPfwd) corresponding to the 5′ end of the RNase MRP RNA and
containing the promoter sequence for T7 RNA polymerase and a reverse oli-
gonucleotide (MRPrev) complementary to the 3′ end of the RNase MRP RNA.
In vitro transcription was performed essentially as described above. After trans-
cription, the RNA was purified by phenol/chloroform/isoamylalcohol extraction
and precipitated with ethanol.
2.4. Reconstitution of S1-tagged RNase MRP complexes
RNase MRP particles were partially purified from a HEp-2 cell extract by
glycerol density gradient sedimentation as described previously [25]. Gradient
fractions (500μl) were collected and the separationwasmonitored by analyzing the
presence of RNase MRP RNA, U3 snoRNA and RNase P activity in each of the
fractions. Peak fractions 5–9 (12S peak) were pooled and stored in small aliquots
at −70 °C. The 12S RNase MRP complexes were (partially) disrupted by in-
creasing the KCl concentration to 1 M (unless stated otherwise) and incubating for
30 min at 0 °C [28]. One microgram of purified S1-tagged (mutant) RNase MRP
RNA (see above) was added and subsequently the KCl concentration was reduced
to 150mMby addingwater and buffer components (150mMKCl; 10mMHEPES/
KOH, pH 7.6 and 0.5 mM DTE) to a total volume of 7.5 ml. Reconstitution was
performed for 20 min at 30 °C. Simultaneously, protein A-agarose beads were
coupled with normal rabbit serum, rabbit anti-U3-55K antiserum [29], mouse anti-
Rpp20 monoclonal antibody (ModiQuest), rabbit anti-Rpp25 antiserum [30] or
rabbit anti-Rpp38 antiserum [31] in IPP500 (10 mMTris–HCl, pH 8.0; 0.05%NP-
40; 500 mM NaCl). The beads were washed twice with IPP500 and once with
IPP150 (like IPP500, but with 150 mM NaCl). Immunoprecipitations were per-
formed with 1250 μl reconstitution mixture under continuous agitation at 4 °C for
2 h. After immunoprecipitation, the beads were washed three times with IPP150.
RNA was isolated from the beads using Trizol reagent (Invitrogen) followed by
isopropanol precipitation. Co-precipitated RNAs were analysed by denaturing
PAGE and northern blot hybridization using radiolabeled riboprobes recognizing
the (S1-tagged) RNase MRP RNA and the U3 snoRNA. The results were quan-
tified by phosphorimaging and processed to determine the relative reconstitution
efficiencies (RRE) of the tagged full-length RNAs with Rpp20, Rpp25 and Rpp38.
First, the reconstitution efficiency of the tagged wild type RNase MRP RNAwas
determined by comparing the precipitated S1-tagged MRP RNA/endogenous
MRP RNA ratio with the ratio of these RNAs in the reconstituted material. The
reconstitution efficiency for each of the proteins with the mutant RNAs was
determined similarly and compared with the efficiency of the wild type RNase
MRP RNA to yield the RREs.
2.5. NMR spectroscopy
The 18-mer RNA oligonucleotides representing the wild type apical stem-
loop of P3 and its 40GNAvariant were purchased from IBA GmbH (Göttingen,
Germany). To stabilize the short hairpins used for the NMR studies an additional
G–C base pair was added to the stems. The RNAs were directly dissolved in
90% H2O/10% D2O, briefly heated for 2 min at 85 °C followed by snap-cooling
in iced water to promote hairpin formation. The pH was adjusted to 6.8 (meter
458 T.J.M. Welting et al. / Biochimica et Biophysica Acta 1783 (2008) 455–466reading). Final concentration of the RNA samples was 0.5 mM. NMR spectra
were acquired on Varian Inova 500 MHz and 800 MHz spectrometers. For the
assignment of exchangeable imino protons two-dimensional NOESY spectra
were recorded at 800 MHz with a 300 ms mixing time using a jump return pulse
for water suppression [32].3. Results
3.1. Binding of Rpp25 to the P3 domain of RNase MRP
Recently we have shown that Rpp25 and Rpp20 form a
stable heterodimer that binds to the P3 domain of RNase MRP
[21,26]. Rpp25 displays a higher binding affinity for P3 RNA
than Rpp20 and is able to interact with the P3 domain also in the
absence of Rpp20. To investigate whether the P3 domain is
sufficient for the interaction with Rpp25, an RNA molecule
comprising only the P3 domain was generated and its inter-
action with Rpp25 studied using a GST pull-down approach.
GGP3AAGCU RNA, derived from a previously described
transcription construct for the P3 domain [19], contains two
additional guanosines at the 5′ end that form part of the T7 RNA
polymerase promoter and a residual AAGCU sequence at the 3′
end that originates from linearizing the plasmid DNA template
with HindIII. The results in Fig. 1 (lanes 1–3) show that this
GGP3AAGCU RNA interacts specifically with GST-Rpp25. To
further investigate the importance of the additional nucleotides
at the 5′ and 3′ ends, a P3 RNA (referred to as P3) lacking any
extra nucleotides was generated by in vitro transcription. Sur-
prisingly, the absence of flanking nucleotides did not lead to aFig. 1. Binding of GST-Rpp25 to the RNase MRP RNA P3 domain. Radiolabele
recombinant bacterially expressed GST-Rpp25 or GST coupled to glutathion
and autoradiography. For each RNA, 10% of the amount used in the pull-down was
Lanes 1–3: P3 RNA transcribed from linearized plasmid DNAwith two T7 RNA polym
Lanes 4–6: P3RNAwithout additional nucleotides. Lanes 7–9: P3RNAwith four additi
two additional 5′ nucleotides derived from the T7 RNA polymerase promoter (GG). Ldetectable interaction of the P3 domain with GST-Rpp25 (lanes
4–6). These data suggested that at least some flanking nucle-
otides are required for the binding of Rpp25. Therefore, three
additional P3 RNA variants were generated, containing either
two G's at the 5′ end, four nucleotides at the 3′ end (GGAA,
corresponding to the flanking sequence in the wild type RNase
MRP RNA), or both. The addition of two G's at the 5′ end
(lanes 10–12) restored the interaction with GST-Rpp25, and the
efficiency of precipitation was comparable to that observed with
GGP3AAGCU. In contrast, the addition of GGAA to the 3′ end
did not seem to lead to detectable binding (lanes 7–9). How-
ever, the combination of 5′ GG and 3′ GGAA further enhanced
the efficiency of binding (lanes 13–15) to levels comparable
with those observed with the complete RNase MRP RNA (not
shown). These results show that additional bases at the 5′ and 3′
end of the P3 domain are required for the efficient interaction
between Rpp25 and the P3 domain of RNase MRP RNA
in vitro. Because the identity of these nucleotides, at least at the
3′ end, did not seem to be important, these effects may be
explained by stabilization of the P3 structure by the flanking
nucleotides. Because of its high precipitation efficiency we de-
cided to use theGGP3GGAAconfiguration for further analysis of
the P3 mutants.
3.2. The effect of P3 mutations on Rpp25 binding
All reported CHH-associated mutations in the P3 domain
of RNase MRP RNA occur in sequences which are com-
pletely conserved among vertebrate RNase MRP RNAs ([4] andd P3 domain-containing RNAs were transcribed in vitro and incubated with
e-Sepharose. Co-precipitating RNAs were analysed by denaturing PAGE
analysed in parallel. The positions of the RNAs are indicated by asterisks (⁎).
erase promoter (5′ GG) and HindIII restriction site (3′AAGCU) nucleotides [19].
onal 3′ nucleotides derived fromRNaseMRP (GGAA). Lanes 10–12: P3RNAwith
anes 13–15: P3 RNAwith both GG at the 5′ end and GGAA at the 3′ end.
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only analysed the effect of CHH-associated P3 mutations on
protein binding, but also mutated other conserved nucleotides to
study their importance. In total, 15 different P3 RNA mutants,
5 of whom corresponded to CHH-associated mutations, were
generated (Fig. 2A). As a control, wild type MRP1-82 RNAwas
transcribed from a plasmid template and combined with each of
the P3 mutants in the GST pull-down assay. The relative pull-
down efficiencies (RPE) calculated from the results of three
independent experiments are shown in Fig. 2B. Most of the P3
mutations had no or only a small effect (less than two-fold change)
on the precipitation efficiency by GST-Rpp25. Interestingly, the
substitution of nucleotides 29–31 (UAC to CGU; mutant no. 2)
and the substitution of nucleotide 35 (C to U; mutant no. 4) had
a positive effect on the precipitation efficiency. It should, how-
ever, be noted that mutant no. 2 displayed a great variability
in precipitation efficiency. Although mutant no. 4 was bound
more efficiently than wild type P3 RNA, the substitution of bothFig. 2. Interaction of human RNase MRP RNA P3 mutants with Rpp25. A. Schematic
of human RNase MRP RNA with the sequence and numbering of the nucleotides
transcribed in vitro and incubated with recombinant GST-Rpp25 or GST coupled t
PAGE and quantified by phosphorimaging. For each mutant the relative pull-down eff
indicate the standard deviation (note that the standard deviation of mutant 13 is very s
as depicted in Fig. 2A. The results for CHH-associated mutants are indicated in darnucleotides 34 and 35 (AC to GU; mutant no. 3) had almost no
effect on binding of Rpp25. For 5 mutants we observed relative
precipitation efficiencies of less than 50% as compared to wild
type P3 RNA. These mutations are: 40GNA (no. 5), 42CNG/
47UNA (no. 8), 46GNC (no. 9), 47UNC (no. 10) and 63CNU
(no. 13). Because the 47UNC substitution reduced the precipita-
tion efficiency to 12% and the 42CNU (no.7) substitution has only
a moderate effect (72% RPE), it is very likely that the low pre-
cipitation efficiency (13%) observed for the mutant in which both
residues are changed, 42CNG/47UNA (no. 8), is caused by the
alteration at position 47. Also the 46GNC (no. 9) substitution
significantly reduced the precipitation efficiency (37%). Both
residues 46 and 47 are located in the apical loop of the P3 domain
and are among the most highly conserved residues in the P3
domain of the vertebrate RNase MRP RNA (Supplementary
Fig. 1). The guanosine at position 40 is part of the P3b stem.
Although the nucleotides in this stem are not completely con-
served, a guanosine is found at this position in each of the RNaserepresentation of the secondary structure of the P3 domain (nucleotides 22–67)
(black boxes) and mutations indicated. B. Radiolabeled (mutant) RNAs were
o glutathione-Sepharose. Co-precipitating RNAs were analysed by denaturing
iciency (RPE) was determined for three independent experiments. The error bars
mall). The numbers below the graph correspond to the numbering of the mutants,
k grey.
460 T.J.M. Welting et al. / Biochimica et Biophysica Acta 1783 (2008) 455–466MRP RNAs and a substitution is always compensated by a
complementary substitution, maintaining the capacity to form
a stem.Recently, we have demonstrated that Rpp20 does not bind to
the P3 domain in the absence of Rpp25 [21]. As expected, also
the mutant P3 RNAs were not bound by the Rpp20 protein, as
461T.J.M. Welting et al. / Biochimica et Biophysica Acta 1783 (2008) 455–466demonstrated by the results of GST pull-down analyses (data
not shown).
3.3. The effect of P3 mutations on RNase MRP complex
formation
To investigate whether the reduced binding efficiency of
Rpp25 with some of the P3 mutants also affected RNase MRP
particle assembly, mutations were introduced into the full-length
human RNase MRP RNA and the capacity to reconstitute into
RNase MRP complexes was investigated. Reconstitution of
RNase MRP complexes was performed with RNase MRP com-
plexes partially purified from a HEp-2 cell extract and was
monitored by the analysis of RNAs co-immunoprecipitated with
antibodies to RNase MRP protein subunits. To discriminate
between the endogenous (HEp-2 cell) and exogenous RNA, an
S1-aptamer (104 nucleotides, including flanking residues) was
introduced into the latter between nucleotide 158 and 159. The
insertion of the S1 aptamer tag at this position did not affect
Rpp38 binding (data not shown and Fig. 3A). To allow re-
constitution to take place, the RNaseMRP complexes in the HEp-
2 cell fractions were disrupted by increasing the KCl concentra-
tion to 1M.After the addition of the in vitro transcribed S1-tagged
RNAs reconstitution was initiated by adjusting the salt concen-
tration to physiological levels. The concentration of KCl required
for this reconstitution procedure was empirically determined by
performing a reconstitution experiment at different KCl concen-
trations. We observed efficient reconstitution with S1-tagged
human RNase MRP RNA after complex dissociation with 1 M
KCl and subsequent dilution (Fig. 3A, lane 17). Under these
conditions not onlyRpp25, but also hPop1 andRpp38were found
to associate with the S1-tagged RNase MRP RNA (lanes 16, 18).
Although the reconstitution efficiency was even higher after
treatment with 1.5 M KCl, for practical reasons we decided to
choose 1 MKCl for the analysis of P3 mutants. The specificity of
this assay was established by the lack of RNase MRP RNA co-
precipitation with anti-U3-55K antibodies (directed to a U3
snoRNP component which is also present in RNase MRP con-
taining fractions used for this experiment) and the lack of U3
snoRNA co-precipitation with antibodies against hPop1, Rpp25
and Rpp38. Additional evidence for the correct assembly of the
tagged RNA into RNase MRP complexes comes from glycerol
gradient sedimentation analyses, which demonstrated that the
tagged RNA assembles into complexes that co-fractionate with
the wild-type RNA in the gradients (results not shown).
Five P3 mutations, 35CNU (mutant 4), 40GNA (mutant 5),
47UNC (mutant 10), 63CNU (mutant 13) and 64UNC (mutant 14),Fig. 3. Reconstitution of RNase MRP in HEp-2 cell fractions. A. Partially purified
concentrations, as indicated below the lanes. In vitro transcribed S1-tagged human RNas
complexeswere subjected to immunoprecipitation using polyclonal antibodies specifical
anti-55K serum were used. Co-immunoprecipitated RNAs were isolated and separated
riboprobes and visualized by autoradiography. The positions of the RNAs are indicated o
parallel (10% input). B. RNase MRP reconstitution was performed after disassembly of
human RNase MRP RNAwas reconstituted and analysed as described above. The posi
RNA, Lanes 7–12:mutant 35CNU,Lanes 13–18:mutant 40GNA,Lanes 19–24:mutant
of the reconstitution as shown in B were quantified by phosphorimaging. For each mut
determined for two independent experiments. The error bars indicate the spreading. CHwhich were CHH-associated and/or had a significant effect on
Rpp25-binding to the P3 domain, were introduced into the S1-
tagged RNase MRP RNA and their reconstitution was analysed
by co-immunoprecipitation with Rpp20, Rpp25 and Rpp38. Note
that, whereas Rpp25 directly interacts with the P3 domain, the
association of Rpp20 with this domain is strongly dependent on
its heterodimerization with Rpp25 [21] and that Rpp38 interacts
with another part of the RNase MRP RNA and was included as a
control. As negative controls normal rabbit serum and rabbit anti-
U3-55K serum were used. Fig. 3B shows the northern blot hy-
bridization data of the reconstitution experiments with these
mutants. Again the endogenous RNaseMRPRNAwas efficiently
precipitated, as is the wild type S1-tagged RNase MRP RNA
(lanes 4–6). After quantification by phosphorimaging, the relative
reconstitution efficiency (RRE) of the wild type S1-tagged RNase
MRP RNAwith Rpp20, Rpp25 and Rpp38 was calculated. Sub-
sequently, these ratios were used to determine the RRE of the
mutant RNase MRP RNAs (lanes 7–36). As expected, the P3
mutations had no or only a small effect on Rpp38 association with
full-length RNase MRP RNA. However, the P3 mutations sig-
nificantly affected the association of Rpp20 and Rpp25 with full-
length RNase MRP RNA (Fig. 3B/C). Relatively low levels
of reconstitution were observed for mutants 35CNU, 40GNA,
47UNC and 63CNU, whereas the reconstitution with 64UNC was
comparable to that of the wild type RNA. These reconstitution
data correlate well with GST pull-down data, with the striking
exception of mutant 35CNU, which appeared to enhance the
binding of GST-Rpp25 to the P3 domain (Fig. 2B), but had a
negative effect on the reconstitution with full-length RNase MRP
RNA. The results obtained with the anti-Rpp20 antibodies were
very similar to the results for the anti-Rpp25 antibodies, which is
most likely related to the stable heterodimerisation of Rpp20 and
Rpp25.With regard to this it is important to note that 1MKClwill
not lead to the dissociation of the Rpp25–Rpp20 dimer itself [21].
Neither (S1-tagged) RNase MRP RNA nor U3 snoRNA was
precipitated with the normal rabbit serum and only U3 snoRNA
was specifically precipitated from the reconstitution mixture with
anti-U3-55K antibodies. The specificity of this assay was further
confirmed by the lack of U3 snoRNA co-precipitation with the
antibodies to Rpp20, Rpp25 and Rpp38.
3.4. The effect of the 40GNA mutation on the structure of the P3
hairpin
The effect of mutations on the association of protein subunits
may be either due to the loss of direct contacts and the result-
ing decrease in binding affinity, or to structural changes in the12S RNase MRP particles from HEp-2 cells were disrupted by increasing KCl
eMRP RNAwas added and allowed to reconstitute at 150 mMKCl. Reconstituted
ly recognizing hPop1,Rpp25orRpp38.As controls normal rabbit serum (NRS) and
by denaturing PAGE. RNAs were detected by northern blotting using radiolabeled
n the left. From 10%of the reconstitutedmaterial RNAwas isolated and analysed in
12S particles in the presence of 1.0MKCl. In vitro transcribed S1-tagged (mutant)
tions of the RNAs are indicated on the left. Lanes 1–6: wild type S1-tagged MRP
47UNC,Lanes 25–30:mutant 63CNU), Lanes 31–36mutant 64UNC.C.The results
ant the relative reconstitution efficiency (RRE) with Rpp20, Rpp25 or Rpp38 was
H-associated mutations are indicated in grey.
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substitutions. For obvious reasons, conformational changes are
more likely caused by the alteration of nucleotides involved in
basepairing interactions. The secondary structure of the P3 do-
main depicted in Fig. 2 is supported by both phylogenetic and
biochemical structure probing data. In addition, NMR analysis of
the complete P3 RNA domain supported the base pairing il-
lustrated in Fig. 2A, and thus argues against the formation of
alternative conformations for this RNA (results not shown). The
data presented above indicate that the binding of Rpp25 to the P3
domain is primarily mediated by interactions with the apical
hairpin of the P3 domain. One of the CHH-associated mutations
situated in the stem of this hairpin, 40GNA, had a drastic effect on
Rpp25-binding and RNase MRP complex formation. To shed
more light on the potential structural changes induced by thisFig. 4. Secondary structure of the apical stem-loop of the P3 domain. The upper
panel shows the mfold structure prediction of the apical stem-loop of the wild
type (wt) P3 domain of the human RNase MRP RNA and the potential pseudo-
triloop structure of this RNA domain. The numbers correspond to the nucle-
otides of the complete human RNase MRP RNA. The lower panel shows the
mfold structure prediction of mutants 47UNC and 40GNA. For mutant 40GNA
two possible structures with similar free energy values were predicted. Note that
for NMR analysis an additional G–C clamp was placed at the ends of the RNAs
(G at 3′ end and C at 5′ end).mutation, we decided to study the structure of the apical stem-loop
in more detail by NMR.
First the structural effect of the 40GNA substitution was
evaluated by using the mfold algorithm [33]. We also looked
at the effect of a loop mutation, 47UNC, which also strongly
affected Rpp25-binding. Two alternative structures for the wild-
type RNA were obtained, which differ by a single base pair
formed between 42C and 46G (Fig. 4). Whereas the 47UNC
substitution in the hairpin loop did not lead to a potential
alternative secondary structure of the hairpin, the mfold pre-
diction of the 40GNA stem variant revealed two alternative
secondary structures, both different from the predicted wild type
hairpin structures (Fig. 4). Two structures are predicted for this
variant by possible slippage of a G–C base pair with the bulged
C. RNA molecules corresponding to the wild type and 40GNA
P3 RNAs were synthesized and investigated by NMR.
The existence of the proposed structure of the wild type apical
P3 hairpinwas confirmed by theNMR spectra. The 1-dimensional
(1D) spectrum reveals five strong peaks between 12 and 15 ppm,
i.e. in the region where typically the imino protons of Watson–
Crick base pairs resonate (Fig. 5A). Four of these could be as-
signed to specific residues from a classic sequential imino to imino
proton walk in the 2D NOESY spectrum (Fig. 5B). Besides the
five strong peaks also two weak peaks are visible in the 1D
spectrum. One at 14 ppm, a typical position for a uridine imino
proton involved in an U–A base pair, and another at 10.8 ppm, in
the region where typically imino protons of non-canonical base
pairs resonate. These probably originate from U48 and a loop
uridine, respectively. The strong peak at 13.4 ppm,which does not
show a connectivity in the 2D NOESY spectrum most probably
arises from the loopG46 residue, forming a base pair with the loop
C42 residue. Formation of this G46–C42 base pair leaves a so-
called pseudo-triloop with the UCU residues in the loop and
bulged U47.
The NMR spectra of the 40GNA variant are markedly dif-
ferent from the wild type, and feature characteristics corre-
sponding to the predicted structural differences (Fig. 4). The 1D
imino proton spectrum of the 40GNA hairpin shows enhanced
broadening of several resonances (Fig. 5A). This broadening
effect originates from enhanced imino proton exchange with
solvent water, most probably caused by weakening of the stem
due to the introduction of a bulged C. The 2D NOESY of this
hairpin only shows connectivities between two different G–C/
A–U base pair steps (results not shown). Again interruption of
the sequential walk, preventing assignment of resonances, is
caused by the presence of the bulged C, which renders the imino
proton signals of adjacent base pairs too weak to be detected in
this experiment. Thus, although we were not able to assign these
spectra or to distinguish between the proposed forms, the NMR
data clearly indicate structures different from the wild type
hairpin and satisfactorily match the structures depicted in Fig. 4.
4. Discussion
The most frequently occurring CHH-associated mutation in
the human RNase MRP RNA, 70ANG, which is located in a
region of the RNA (the J3/4 domain) that is predicted to be
463T.J.M. Welting et al. / Biochimica et Biophysica Acta 1783 (2008) 455–466essential for its catalytic activity [34], has been suggested
to impair the RNase MRP function directly [2]. In addition to
70ANG, currently 57 other CHH-associated mutations in theFig. 5. Analysis of the structure of the apical stem-loop of P3 by nuclear magnetic res
type apical stem-loop (upper panel) and mutant 40GNA (lower panel) recorded at
indicated. Single or double asterisks in the lower panel indicate connected imino proto
2D NOESY spectrum of the P3 wild type apical stem-loop recorded at 5 °C at 800
indicated by residue type and number. The sequential imino proton walk is traced ocoding sequence of the RMRP gene have been reported [4,35].
The mechanisms by which these mutations affect the struc-
ture and function of RNase MRP have not been addressedonance. A. One-dimensional 1H NMR spectra (imino proton region) of the wild
5 °C at 800 MHz. The assignment of peaks to residues numbered in Fig. 4 is
ns observed as NOE cross peaks in the 2D NOESYexperiment. B. Section of the
MHz, showing the imino proton region. Assignments of the diagonal peaks are
ut.
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for an impairment of RNase MRP assembly by CHH-associated
(and other) mutations in the P3 domain.
4.1. The P3 domain of RNase MRP RNA
Several lines of evidence indicate that the P3 domain is among
the most important elements of the RNase MRP RNA. The P3
domain belongs to the most highly conserved elements of this
RNA [36], it contains the major binding sites for protein subunits
and is required for assembly of the ribonucleoprotein particles
[19] and its nucleolar accumulation [22]. Its secondary structure
consists of a hairpin of which the stem is interrupted by an internal
loop. The results of our NMR experiments strongly suggest that a
pseudo-triloop is formed in the apical stem-loop of the RNase
MRP P3 domain as a result of basepairing between C42 and G46.
A comparable pseudo-triloop present in the encapsidation signal
of hepatitis B virus yields a comparable chemical shift signature
[37] giving further support to our interpretation of the spectra. In
this respect it is also important to note that the C residue at the
most 5′ position and the G residue at the one but last position in
the hairpin loop of the P3 domain are fully conserved in vertebrate
RNase MRP and RNase P RNA (Supplementary Fig. 1). This
distinct loop folding principle [38,39] has been recognized as a
protein recognition site in various RNA-protein complexes and
was found to be essential for hepatitis B virus and brome mosaic
virus replication [37,38]. A pseudo-triloop has also been reported
to occur in another nucleolar endoribonuclease, the Saccharo-
myces cerevisiae U3 snoRNA [40]. Besides being involved in
protein-binding, the RNaseMRPP3 pseudo-triloopmay also play
a role in tertiary interactions.
To understand the effects of CHH-associated mutations on
RNase MRP function, it is important to know whether they
induce structural alterations in the folding of the RNA. The
nucleotide substitutions at positions 35 and 63, and the dup-
lication of nucleotides 45–53 are not predicted to alter the
secondary structure. However, mutations 40GNA and 64UNC
are expected to have more severe effects, because they disrupt
the basepairing at these positions. Our NMR analysis of mutant
40GNA indeed confirmed the existence of an alternative se-
condary structure in the apical stem-loop of P3. Importantly,
although a regular triloop is formed, the bulged nucleotide is not
present in this mutant and therefore the pseudo-triloop structure
is not formed in the alternative configurations of this mutant.
4.2. The binding of the Rpp25-Rpp20 dimer to the P3 domain
Previously, we have demonstrated that the Rpp25 and Rpp20
subunits of RNase MRP form a stable heterodimer for which the
main binding site resides in the P3 domain [20,21]. Our data
also suggested that the association of the Rpp25–Rpp20 dimer
with RNase MRP is transient. The Rpp25–Rpp20 dimer was
proposed to dissociate from RNase MRP either before or during
its assembly with pre-ribosomes and to reassociate after the
RNase MRP catalysed processing event of pre-rRNA [25].
Rpp25 directly contacts the P3 domain of the RNase MRP RNA
[20,21,24]. The results we obtained with the P3 mutants suggestthat the main determinants for Rpp25 binding reside in the
apical stem-loop of the P3 domain, because a strong reduction
of the Rpp25 binding efficiency was observed with mutants
40GNA, 47UNC, 46GNC and 42CNG/47UNA, whereas muta-
tions in other regions of P3 had no or weaker effects. Moreover,
these data are fully consistent with the binding of Rpp25 to the
putative pseudo-triloop structure, because each of these muta-
tions will interfere with the formation of the latter structure.
Note that the 42CNU mutation, which had only a minor effect
on Rpp25 binding, still allows the pseudo-triloop to be formed,
although it may be less stable. The sequence of the stem of the
apical stem-loop is probably not very important for Rpp25
binding, because mutations 6 and 11, which alter the sequence
of the stem but still allow basepairing, appeared to have only
mild effects on Rpp25 binding. Due to the sequence com-
plementarity between distinct molecules, the in vitro transcribed
P3 RNAs might form dimers or multimers. This possibility was
investigated by non-denaturing gel electrophoresis and the
results showed that, although dimer formation was observed for
a subset of molecules, the dimer:monomer ratio observed for the
various mutants was very similar to that of the wild-type RNA
(results not shown). The electrophoretic mobility of these
molecules also did not indicate the existence of multiple struc-
tural forms. Therefore, the effects of the mutations on Rpp25
binding are not due to structural changes or changes in dimer
formation as a result of the mutations.
Taken together, our data strongly suggest that 42C–46G base-
pairing generates a pseudo-triloop-like structure which is required
for Rpp25 binding, and that the bulged U-residue (47U) is cri-
tically important for this interaction.
In the cellular environment, Rpp25 most likely binds as part of
the Rpp25–Rpp20 heterodimer to the P3 domain of RNase MRP
RNA. In agreement with this, the effects of the RNaseMRP RNA
mutations on the association of Rpp25 and Rpp20 in the re-
constitution assay (Fig. 3) are very similar. Rpp20 is predicted to
contribute to the binding of the Rpp25–Rpp20 dimer to the P3
domain, because close contacts between Rpp20 and the RNA
have been detected by UV-crosslinking and Rpp20 enhances the
efficiency of Rpp25 binding to the P3 domain [19–21]. Our data
do not provide insight into the region of the P3 domain that might
be contacted byRpp20.However, based upon a comparison of the
results of the GST pull-down and the ribonucleoprotein particle
reconstitution experiments, it is tempting to speculate that residue
35C is involved in the Rpp20-RNA interaction. Mutation of
this residue into a U significantly reduced the efficiency of re-
constitution, whereas this mutation did not reduce the binding by
GST-Rpp25.
4.3. CHH-associated mutations in the P3 domain
Up to now, five CHH-associated mutations have been
reported to occur in the P3 domain of RNase MRP RNA. The
effect of each of these mutations on the binding of Rpp25 was
investigated in the present study. In agreement with the structure
of the proposed binding site for Rpp25 (see above) the 40GNA
mutation severely affected the binding of this protein to the
RNA, whereas the other four mutations had no or much less
465T.J.M. Welting et al. / Biochimica et Biophysica Acta 1783 (2008) 455–466effect. Only 63CNU partially reduced the efficiency by which
GST-Rpp25 binds to the P3 RNA. This effect may be caused
by a destabilisation of the proximal P3 stem. Indeed the results
presented in Fig. 1 suggest that the stability of the secondary
structure in this region is important for Rpp25 binding. How-
ever, 64UNC is expected to reduce the stability of the proximal
stem more severely than 63CNU, but this mutation did not
detectably affect the binding of Rpp25. Therefore, the mo-
lecular basis for the reduced binding efficiency of Rpp25 to
mutant 63CNU is currently unclear.
In the reconstitution assay all CHH-associated P3 mutations
analysed affected the association of both Rpp25 and Rpp20,
whereas the association of Rpp38, which is known to interact
with another region of the RNase MRP RNA [19,26], was not
affected. These results indicate that in the context of the com-
plete RNase MRP RNA and in the presence of all RNase MRP
proteins not only 40GNA, but also the CHH-associated muta-
tions 35CNU, 63CNU and 64UNC reduce the binding efficiency
of Rpp25 and Rpp20, which under our experimental conditions
most likely bind as a dimer. These data suggest that most, if not
all of the CHH mutations in the P3 domain interfere with the
assembly of the RNase MRP ribonucleoprotein particle. Since
the Rpp25–Rpp20 dimer is believed to go through a cycle of
dissociation and reassociation during the conversion of a sub-
strate RNA by RNase MRP, the P3 mutations will interfere with
this cycle, thereby reducing the functional activity of RNase
MRP. It should be noted that also the hPop1 protein has been
reported to require the P3 region for its association with RNase
MRP [26,41]. This protein may either bind to the P3 RNA
directly or to proteins, e.g. Rpp25 and/or Rpp20 which bind to
the P3 RNA. Although we did not find an effect on the hPop1
interaction efficiency for any of the P3 mutations tested (our
unpublished data), further studies will be required to investigate
to what extent the CHH-associated P3 mutations affect the
association with hPop1. The lack of interference of the P3
mutations that affect Rpp25–Rpp20 binding with hPop1 as-
sociation and the association of hPop1 with 60–80S pre-rRNA
complexes [25], which are devoid of Rpp25–Rpp20, strongly
suggest that hPop1 associates with the P3 domain in a Rpp25–
Rpp20 independent manner.
In most CHH patients a mutation in the coding sequence of the
RNase MRP RNA is accompanied by a mutation in the promoter
region of the other allele. The latter mutation is believed to silence
this allele,meaning that only themutatedRNA is expressed in such
patients. An interesting exception is a patient in which one allele
carries the 40GNA and the other the 63CNU mutation [4]. In this
patient probably two mutant RNase MRP RNAs are expressed,
both ofwhich display an impaired P3-dependent ribonucleoprotein
assembly phenotype.
In conclusion, our data not only shed more light on the in-
teraction of the Rpp25 (and Rpp20) protein with the RNase MRP
RNA, but also provide insight into the molecular mechanism by
which mutations in the P3 domain of RNase MRP may lead to
cartilage–hair hypoplasia. It will be interesting to investigate
whether such mechanisms are also relevant for other diseases
caused by mutations in (structural) RNAs (e.g. dyskeratosis con-
genita [42] and myotonic dystrophy [43]).Acknowledgments
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